Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to describe the treatments received and outcomes of patients with metastatic colorectal cancer, what percentage of these patients have K-Ras mutation of the tumor, and to describe the costs of treatments. Information will also be collected regarding risk factors, variables among treatment centers and patients, and explorative analyses will be done to try to identify factors that impact prognosis and factors that predict tolerability and response to treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| metastatic colorectal cancer |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| percentage of patients enrolled in a clinical trial | two years | |
| percentage of patients who undergo K-Ras mutation study | 2 years | |
| Percentage of patients with K-Ras mutation | 2 years |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| metastatic colorectal cancer treatments used in clinical practice, according to participating center | 2 years | |
| patient outcome according to K-Ras status | two years | |
| estimated costs per treatment per center |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients at participating Institutes who are candidate for first-line treatment of metastatic colorectal cancer
Not provided
| Name | Affiliation | Role |
|---|---|---|
| R. V. Iaffaioli, M.D. | National Cancer Institute, Naples | Principal Investigator |
| G. Nasti, M.D. | National Cancer Institute, Naples | Principal Investigator |
| M. C. Piccirillo, M.D. | National Cancer Institute, Naples | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| A.O.G. Rummo | Benevento | Italy | ||||
| Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Entero-proctologico |
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
| 2 years |
| disease outcome per patient per treatment received | 2 years |
| factors that influence patient prognosis | exploratory analyses | 2 years |
| predictive factors for response to treatment | exploratory analyses | 5 years |
| Naples |
| Italy |
| Ospedale Civile Umberto I | Nocera Inferiore | Italy |
| C:R.O. Regione Basilicata Ospedale Giustino Fortunato | Rionero in Vulture | Italy |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |